Partnering With Family Members to Prevent, Detect and Manage Delirium in Critically Ill Patients.
Delirium, Intensive Care Unit Delirium, Post Intensive Care Unit Syndrome
About this trial
This is an interventional prevention trial for Delirium focused on measuring delirium, intensive care unit, critically ill, delirium detection, delirium prevention, delirium education, delirium management, psychological distress, post intensive care syndrome, post intensive care syndrome family
Eligibility Criteria
Inclusion Criteria:
- Intensive care unit (ICU) patients aged 18+ anticipated to remain admitted in the ICU for at least a further 24 hours to complete the intervention and all assessments at least once
- ICU patient has a caregiver (i.e., family member or friend) present
- Richmond Agitation Sedation Scale (RASS) ≥-3
- The ability to provide informed consent (both patient and family member; surrogate consent possible)
- The ability to communicate with research staff (fluent in English, no hearing or visual impairment that precludes communication)
Exclusion Criteria:
- Primary direct brain injury (e.g., traumatic brain injury, subarachnoid hemorrhage) with a Glasgow Coma Scale score of <9
Sites / Locations
- Peter Lougheed Centre
- Foothills Medical CentreRecruiting
- Rockyview General Hospital
- South Health Campus
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Control Group
Intervention Group
Patients and families will receive standard care, which is an informational pamphlet on ICU delirium upon admission. The intervention group will also receive the same pamphlet.
Patients and families will receive standard care, which is an informational pamphlet on ICU delirium upon admission. Additionally, they will receive delirium education on prevention and management of delirium.